المؤلفون: Mandl, Thomas, Jacobsson, Lennart

المصدر: Läkartidningen. 99(51-52):93-5189

مصطلحات موضوعية: Spondylitis, Recurrence, Middle Age, Methotrexate: administration & dosage, Ankylosing: immunology, Tumor Necrosis Factor: antagonists & inhibitors, Treatment Outcome, Tumor Necrosis Factor: immunology, English Abstract, Combination, Ankylosing: drug therapy, Human, Follow-Up Studies, Male, Female, Psoriatic: immunology, Drug Therapy, Psoriatic: drug therapy, Arthritis, Monoclonal: administration & dosage, Antirheumatic Agents: administration & dosage, Adult, Antibodies, Medicin och hälsovetenskap, Klinisk medicin, Annan klinisk medicin, Medical and Health Sciences, Clinical Medicine, Other Clinical Medicine

الوصول الحر: https://lup.lub.lu.se/record/114449Test
http://ltarkiv.lakartidningen.se/artNo25935Test

المؤلفون: Glintborg, Bente, Gudbjornsson, Bjorn, Steen Krogh, Niels, Omerovic, Emina, Manilo, Natalia, Holland-Fischer, Mette, Lindegaard, Hanne M, Gitte Loft, Anne, Nordin, Henrik, Johnsen, Laura, Flejsborg Oeftiger, Sussi, Hansen, Annette, Rasmussen, Claus, Grondal, Gerdur, Jon Geirsson, Arni, Lund Hetland, Merete

المساهمون: Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. glintborg@dadlnet.dk. 2Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 4Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, Center for Rheumatology Research (ICEBIO), Landspitali University Hospital of Iceland, Faculty of Medicine, University of Iceland, Reykjavik, Iceland, Zitelab Aps, Department of Rheumatology, Frederiksberg Hospital, Copenhagen, Department of Rheumatology, Aalborg University Hospital, Aalborg, Department of Rheumatology, Odense University Hospital, Odense, Department of Rheumatology, Vejle Sygehus, Sygehus Lillebælt, Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Department of Rheumatology, Helsingør and Hillerød Hospital, Hillerød, Department of Rheumatology, Køge Hospital, Køge, Department of Rheumatology, Gentofte University Hospital, Copenhagen, Department of Rheumatology, Vendsyssel Teaching Hospital, Hjørring, Denmark, Department of Rheumatology, Landspitali University Hospital of Iceland, Reykjavik, Iceland and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

مصطلحات موضوعية: Sóríasis, Lyfjagjöf, Arthritis, Psoriatic/drug therapy, Antirheumatic Agents/therapeutic use, Denmark, Iceland, Registries, Treatment Outcome, Adult, Antibodies, Monoclonal/administration & dosage, Antirheumatic Agents/administration & dosage, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Infusions, Intravenous, Male, Middle Aged, Prospective Studies, Tumor Necrosis Factor-alpha/antagonists & inhibitors

العلاقة: http://dx.doi.org/10.1093/rheumatology/keu252Test; Rheumatology (Oxford) 2014; http://hdl.handle.net/2336/326075Test; Rheumatology (Oxford, England)

الإتاحة: https://doi.org/10.1093/rheumatology/keu252Test
http://hdl.handle.net/2336/326075Test

المساهمون: Jung-Sun Kim, Sang-Min Park, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, In Whan Seong, Byung Ok Kim, Hyeon-Cheol Gwon, Bum Kee Hong, Seung-Jae Tahk, Seong-Wook Park, Chong Jin Kim, Myung-Ho Jeong, Junghan Yoon, Yangsoo Jang, Ko, Young Guk, Kim, Byeong Keuk, Kim, Jung Sun, Park, Sang Min, Jang, Yang Soo, Choi, Dong Hoon, Hong, Myeong Ki, Hong, Bum Kee

المصدر: T201200499.pdf

مصطلحات موضوعية: Aged, Angioplasty, Balloon, Coronary*/statistics & numerical data, Antibodies, Monoclonal/administration & dosage, Combined Modality Therapy, Coronary Angiography, Electrocardiography, Emergency Medical Services/methods, Emergency Medical Services/statistics & numerical data, Female, Follow-Up Studies, Humans, Immunoglobulin Fab Fragments/administration & dosage, Incidence, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Infarction/diagnosis, Myocardial Infarction/drug therapy, Myocardial Infarction/mortality, Platelet Aggregation Inhibitors/administration & dosage, Prospective Studies, Risk Factors, Treatment Outcome, Clotinab, Myocardial infarction, Percutaneous coronary intervention

العلاقة: CIRCULATION JOURNAL; J00534; OAK-2012-00289; https://ir.ymlib.yonsei.ac.kr/handle/22282913/89956Test; T201200499; CIRCULATION JOURNAL, Vol.76(2) : 405-413, 2012

الإتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/89956Test

المؤلفون: Mateos, María-Victoria, Dimopoulos, Meletios A, Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Qi, Ming, San-Miguel, Jesus, ALCYONE Trial Investigators

المساهمون: UCL - (MGD) Service d'hématologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, Clinical sciences, Hematology, Mateos, María-Victoria, Dimopoulos, Meletios A, Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Ming, Qi, San-Miguel, Jesus for the ALCYONE Trial Investigators

المصدر: New England Journal of Medicine, Vol. 378, no. 6, p. 518-528 (2018)

مصطلحات موضوعية: Male, Oncology, Melphalan, Kaplan-Meier Estimate, Bortezomib, Prednisone/administration & dosage, 0302 clinical medicine, Prednisone, bortezomib, melphalan, prednisone, hemic and lymphatic diseases, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Multiple myeloma, Medicine (all), Standard treatment, antineoplastic agentbortezomibdaratumumabmelphalanmonoclonal antibodyprednisone, Antibodies, Monoclonal, General Medicine, Middle Aged, Intention to Treat Analysis, 3. Good health, Survival Rate, 030220 oncology & carcinogenesis, oncology, Female, Infection, Multiple Myeloma, medicine.drug, Adult, Melphalan/administration & dosage, medicine.medical_specialty, Multiple Myeloma/drug therapy, Infections, Antibodies, Monoclonal/administration & dosage, Antibodies, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, Survival rate, Aged, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Daratumumab, Infections/chemically induced, medicine.disease, Follow-Up Studies, Transplantation, Bortezomib/administration & dosage, business, 030215 immunology

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad05469cd382ea0c0c730507710cf6cTest
https://doi.org/10.1056/nejmoa1714678Test

المساهمون: JEONG HUN BAE, CHRISTOPHER SEUNGKYU LEE, SUNG CHUL LEE, Lee, Sung Chul, Lee, Seung Kyu

مصطلحات موضوعية: Adolescent, Adult, Aged, Antibodies, Monoclonal/administration & dosage, Monoclonal/adverse effects, Monoclonal, Humanized, Behcet Syndrome/complications, Bevacizumab, Female, Follow-Up Studies, Fovea Centralis/drug effects, Fovea Centralis/pathology, Glucocorticoids/administration & dosage, Glucocorticoids/adverse effects, Humans, Injections, Intraocular, Intraocular Pressure/drug effects, Macular혻Edema/complications, Macular혻Edema/drug therapy, Macular혻Edema/pathology, Male, Middle Aged, Retrospective Studies, Tenon Capsule, Tomography, Optical Coherence, Treatment혻Outcome

وصف الملف: 111~118

العلاقة: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES; J02621; OAK-2011-00879; https://ir.ymlib.yonsei.ac.kr/handle/22282913/93405Test; http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00006982-201101000-00017&LSLINK=80&D=ovftTest; T201101907; RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, Vol.31(1) : 111-118, 2011

الإتاحة: https://doi.org/10.1097/IAE.0b013e3181e378afTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/93405Test
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00006982-201101000-00017&LSLINK=80&D=ovftTest

المساهمون: Yeo Jue Byun, Mi In Roh, Sung Chul Lee, Hyoung Jun Koh, Koh, Hyoung Jun, Roh, Mi In, Byun, Yeo Jue, Lee, Sung Chul

مصطلحات موضوعية: Adult, Aged, 80 and over, Angiogenesis Inhibitors/administration & dosage, Antibodies, Monoclonal/administration & dosage, Monoclonal, Humanized, Bevacizumab, Female, Follow-Up Studies, Humans, Immunosuppressive Agents/administration & dosage, Injections, Intraocular, Kaplan-Meier Estimate, Macular Edema/drug therapy, Macular Edema/etiology, Macular Edema/pathology, Male, Middle Aged, Retinal Vein Occlusion/complications, Retinal Vein Occlusion/drug therapy, Retinal Vein Occlusion/pathology, Retrospective Studies, Secondary Prevention, Triamcinolone Acetonide/administration & dosage, Visual Acuity/drug effects, Vitreous Body, Branch retinal vein occlusion

وصف الملف: 963~971

العلاقة: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY; J00951; OAK-2010-00725; https://ir.ymlib.yonsei.ac.kr/handle/22282913/101125Test; http://link.springer.com/article/10.1007%2Fs00417-010-1320-2Test; T201001591; GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, Vol.248(7) : 963-971, 2010

الإتاحة: https://doi.org/10.1007/s00417-010-1320-2Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/101125Test

المؤلفون: Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, De Keyser, Filip

المساهمون: UCL - (SLuc) Service de rhumatologie, UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales

المصدر: Arthritis Research & Therapy, Vol. 12, no. 3, p. R77 (2010)

مصطلحات موضوعية: Antibodies, Monoclonal - administration & dosage, adverse effects, therapeutic use, Antirheumatic Agents - administration & dosage, Infusions, Intravenous, Kaplan-Meier Estimate, Longitudinal Studies, Male, Methotrexate - therapeutic use, Middle Aged, Severity of Illness Index, Treatment Outcome, Arthritis, Rheumatoid - drug therapy, Belgium, Disease Progression, Drug Therapy, Combination, Female, Follow-Up Studies, Health Surveys, Humans

العلاقة: boreal:105553; http://hdl.handle.net/2078.1/105553Test; info:pmid/20459619; urn:ISSN:1478-6354; urn:EISSN:1478-6362

الإتاحة: https://doi.org/10.1186/ar2997Test
http://hdl.handle.net/2078.1/105553Test

المؤلفون: Schmitt-Egenolf, M

المصدر: Information från Läkemedelsverket. 17(5):64

المساهمون: Ji Hun Song, Suk Ho Byeon, Sung Chul Lee, Hyoung Jun Koh, Oh Woong Kwon, Koh, Hyoung Jun, Kwon, Oh Woong, Byeon, Suk Ho, Song, Ji Hun, Lee, Sung Chul

مصطلحات موضوعية: Adult, Aged, 80 and over, Angiogenesis Inhibitors/administration & dosage, Antibodies, Monoclonal/administration & dosage, Monoclonal, Humanized, Bevacizumab, Choroidal Neovascularization/drug therapy, Choroidal Neovascularization/pathology, Follow-Up Studies, Humans, Middle Aged, Retrospective Studies, Tomography, Optical Coherence, Treatment Outcome, Visual Acuity/drug effects, Vitreous Body, Polypoidal choroidal vasculopathy, Choroidal neovascularization, Vascular endothelial growth factor, Intravitreal injection

وصف الملف: 85~92

العلاقة: OPHTHALMOLOGICA; J02431; OAK-2009-00120; https://ir.ymlib.yonsei.ac.kr/handle/22282913/103460Test; http://www.karger.com/Article/FullText/175312Test; T200900184; OPHTHALMOLOGICA, Vol.223(2) : 85-92, 2009

الإتاحة: https://doi.org/10.1159/000175312Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/103460Test
http://www.karger.com/Article/FullText/175312Test

المؤلفون: Raoul, Jean-Luc, Van Laethem, Jean-Luc, Peeters, Marc, Brezault, Catherine, Husseini, Fares, Cals, Laurent, Nippgen, Johannes, Loos, Anja-Helena, Rougier, Philippe

المصدر: BMC cancer, 9

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Adult, Aged, Antibodies, Monoclonal -- administration & dosage -- adverse effects, Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use, Camptothecin -- administration & dosage -- adverse effects -- analogs & derivatives, Colorectal Neoplasms -- drug therapy -- pathology, Diarrhea -- chemically induced, Disease Progression, Dose-Response Relationship, Drug, Drug Administration Schedule, Exanthema -- chemically induced, Female, Fluorouracil -- administration & dosage -- adverse effects, Follow-Up Studies, Humans, Infusions, Intravenous, Leucovorin -- administration & dosage -- adverse effects, Leukopenia -- chemically induced, Male, Middle Aged, Neoplasm Metastasis, Survival Analysis, Treatment Outcome, Vomiting -- chemically induced

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1186/1471-2407-9-112; uri/info:pii/1471-2407-9-112; uri/info:pmid/19366444; uri/info:scp/65649086838; uri/info:pmcid/PMC2678147; https://dipot.ulb.ac.be/dspace/bitstream/2013/111401/4/doi_91656.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111401Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111401Test